2. Professors
  3. SORRENTINO Rosalinda
  4. Curriculum

Curriculum

Rosalinda SORRENTINO Curriculum

Education and Employment positions

2003 Pharmaceutical and Technological Chemistry (109/110), University of Naples, “Federico II”, Italy

2003-2006 PhD in “Drug Discovery and Development” – Experimental Pharmacology Department, University of Naples, “Federico II”, Naples, Italy

10.2005-11.2006 Academic Visitor during the PhD Training at Imperial College in Cardiothoracic Medicine, Critical Care, London Royal Brompton Hospital, UK, under the supervision of prof. Jane A Mitchell

19.12.2006 PhD viva and graduation

1.2007-12.2007 Post Doctoral Researcher, Cedars Sinai, Infectious Diseases and Immunology, Los Angeles, California, USA, under the supervision of prof. Moshe Arditi

1.2008 at 1.09.16 Research Scientist, University of Salerno, Fisciano, Italy, under the mentorship of prof. Aldo Pinto

3.10.2016 Senior Research Scientist, University of Salerno, Fisciano, Italy

2.10.2019 Associate Professor in Pharmacology and Pharmacotherapy, University of Salerno, Italy.

Teaching

Pharmacology, Preclinical Studies, Oncological Pharmacology, Toxicology

Book Chapters

  1. Curator and Author of a book for Experimental Pharmacology. TabEdizioni ISBN:9788892954441
  2. R. Sorrentino and M. Arditi. Innate Immunity, Toll like Receptors and Atherosclerosis: mouse models and methods. Methods Mol Biol. 2009; 517:1-19
  3. Mitchell JA, Sorrentino R, Cartwright N, Paul-Clark MJ. Toll like Receptor 2 as therapeutic target in lung disease. New Drugs and Targets for Respiratory Disease. 2009; 1-4.
  4. Terlizzi M, Pinto A and Sorrentino R. Role of Plasmacytoid Dendritic cells in cancer. eBook. Cancer Immunology and Immunotherapy Chapter 11.
  5. Sorrentino R qand Pinto A. Trattato di Farmacologia III edizione, Capitolo 34: FARMACI ANTISTAMINICI ANTI-H1. 2019: 555-574
  6. Sorrentino R and Pinto A. Capitolo: Antagonisti recettoriali α1 adrenergici (α1-bloccanti). Libro: Farmacologia. Principi di base e applicazione. Minerva Medica. ISBN: 978-8877116994
  7. Sorrentino R and Pinto A. Capitolo: Trattamento farmacologico delle vasculopatie periferiche. Libro: Farmacologia. Principi di base e applicazione. Minerva Medica. ISBN: 978-8877116994
  8. Sorrentino R and Pinto A. Capitolo 5. Eliminazione dei farmaci - il rene e le altre vie di eliminazione, fattori che modificano il processo di eliminazione. Testo di FARMACOCINETICA in fase di completamento editoriale e stampa.

Affiliation to scientific societies and Honours

  • 2024 up today: Member of “IUPHAR Cancer Pharmacology Committee”
  • 2022: Member of the Ethical Committee, ASL NA1/NA2, Campania, Italy
  • 2010 up today: Member Società Italiana di Farmacologia (SIF)
  • Member of the Oncological Pharamcology group at SIF, headed by prof. Mini
  • Co-coordinator of the Clinical Oncological Pharamcology (SIF) headed by prof. Giorgio Minotti
  • Co-coordinator of the ImmunoPharamcology (SIF) headed by prof. Giuseppe Nocentini
  • Member of the Enviornmental Toxicology (SIF) headed by Prof Raffaella Sorrentino
  • 2022 up today. Member and Ambassador of the European Society against cancer (EACR) (EACR33315 member)
  • 2015 up today: Member of the Universal Scientific Education and Research Network, USERN, sezione “Cancer Immunology project: https://usern.tums.ac.ir/Group/Info/CIP
  • 2013 up today: Member of the European Respiratory Society (ERS)
  • 2011 up today: Member of the Società Italiana Immunologia, Immunologia Clinica e Allergologia (SIICA)
  • 2010: Member of the American Association of Immunologists
  • 2008: Member of Scuola di Immunologia Avanzata, ‘Scuola Ceppellini’

Prizes

10.2012 Start Cup Campania Prize 2012 for the project: “Specific reagents for the modulation of plasmacytoid Dendritic cell activity: new targets for diagnosis, prognosis and therapy”

10.2012 Special Award from the UK Council for the project: “ Specific reagents for the modulation of plasmacytoid Dendritic cell activity: new targets for diagnosis, prognosis and therapy”

1.2013 Special Award from the UK Trade&Investment for Future Ideas regarding the project: “Specific reagents for the modulation of plasmacytoid Dendritic cell activity: new targets for diagnosis, prognosis and therapy”

2013 Guest Editor for the Special Issue in Clinical and Developmental Immunology, titled: “Impact of immunotherapy in cancer”

10.2013 Prize for one of the best manuscript submitted to the Italian Society of Pharmacology

03.2014 Travel Grant from the European Respiratory Society for the abstract titled: B cells contribute to S1P-induced lung inflammation

24.05.2017 Award “Borsa della Ricerca 2017” by Z-Cube as best Start-up

2022 Award from “Biomedicine” for a research paper on COVID-19.

Ad hoc Reviewer for:

Journal of Leukocyte Biology, BMC Pulmonary; Journal of Cellular Physiology; American Journal of Pathology; FASEB journal; Journal of Immunology; Clinical and Developmental Immunology; Medical Oncology; Molecular Medicine; Exp Opinion Biological Therapy; Bioorganic & Medicinal Chemistry Letters; Archives of pathology and laboratory; Carcinogenesis, OncoImmunology; Oncotarget; eBook Bentham; Journal of Cancer Research and Clinical Oncology; Pharmacology and Therapeutics, British Journal of Pharmacology; Frontiers Immunology; Frontiers Mucosal Immunity; Life Science Alliance-EMBO J, Journal of Experimental and Clinical cancer research, etc.

External Reviewer for:

-William Harvey Research Institute (WHRI) Marie Curie actions,

-European Research Society (ERS) fellowships,

-SEMAPHORE-FNRS,

-Cancer Research UK,

-Italian Ministry of University and Research, REPRISE.

-Research Foundation – Flanders (Fonds Wetenschappelijk Onderzoek - Vlaanderen, FWO);

- Reumafunds, Dutch Arthritis Association

- Reviewer Cost Action, Loire Valley Institute for Advances Studies Orleans, France.

-PhD Reviewer

Technology Transfer activities:

-02.2015 Foundation of an academic Spin-off, ImmunePharma s.r.l., University of Salerno, Dept. Of Pharmacy (DIFARMA): Chief Executive Officer and R&D Manger

-Patent granted (22.11.16): RM2014A000080, Title: BIOMARCATORI DEL TUMORE POLMONARE, E RELATIVI METODI DIAGNOSTICI E KIT

-PCT/IB2015/051262-filed for EU, USA, China (granted on June 2019), Japan, Canada, Title: LUNG CANCER BIOMARKERS, DIAGNOSTIC METHODS AND KITS THEREOF

- Patent granted (19.08.2022) METODI E KIT PER LA DIAGNOSI DEL TUMORE DEL POLMONE n. 102020000017146.

-Patent pending PCT/IB2021/056326, Title: METHODS and KITS FOR THE DIAGNOSIS OF LUNG CANCER. Pubblication n. WO 2022/013762 A1 PCT/IB2021/056326,

-Scientific Investigator in 5 clinical trials

-11.2011-2012: Know-how Transfer Operator for the University of Salerno

-02.2015-02.2020: R&D Manager and CEO ImmunePharma s.r.l., Dipartimento di Farmacia (DIFARMA), Università degli Studi di Salerno

-05.2018 Know-how Transfer Operator at DIFARMA.